|
⚲
|
| Keyboard |
| Cravatt Benjamin
✚
|
|
|---|---|
| CIK # | 0001819573 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001819573] | |
| 4 | [0001819573] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Alnylam Pharmaceuticals Inc | |
| Cravatt Benjamin | |
| Kyntra Bio Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Kyntra Bio Inc FGEN
Stock Option (Right to Buy) · derivative
|
2024-06-05 | Grant | 70,000 | $0.00 | |
|
Kyntra Bio Inc FGEN
Common Stock
|
2023-06-09 | Sell | 2,178 | $17.51 | 38,137 |
|
Kyntra Bio Inc FGEN
Common Stock
|
2023-06-09 | Sell | 1,766 | $16.75 | 29,580 |
|
Kyntra Bio Inc FGEN
Common Stock
|
2023-06-07 | Grant | 8,289 | $0.00 | |
|
Kyntra Bio Inc FGEN
Stock Option (Right to Buy) · derivative
|
2023-06-07 | Grant | 12,666 | $0.00 | |
|
Kyntra Bio Inc FGEN
Stock Option (Right to Buy) · derivative
|
2022-06-16 | Grant | 25,684 | $0.00 | |
|
Kyntra Bio Inc FGEN
Common Stock
|
2022-06-16 | Grant | 15,777 | $0.00 | |
|
Kyntra Bio Inc FGEN
Stock Option (Right to Buy) · derivative
|
2021-05-26 | Grant | 7,800 | $0.00 | |
|
Kyntra Bio Inc FGEN
Common Stock
|
2021-05-26 | Grant | 4,700 | $0.00 | |
|
Kyntra Bio Inc FGEN
Common Stock
|
2020-08-05 | Grant | 3,914 | $0.00 | |
|
Kyntra Bio Inc FGEN
Stock Option (Right to Buy) · derivative
|
2020-08-05 | Grant | 6,496 | $0.00 | |
|
Kyntra Bio Inc FGEN
Stock Option (Right to Buy) · derivative
|
2020-08-05 | Grant | 10,400 | $0.00 |